These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 34548208)

  • 1. Apremilast downregulates interleukin-17 production and induces splenic regulatory B cells and regulatory T cells in imiquimod-induced psoriasiform dermatitis.
    Uchida H; Kamata M; Shimizu T; Egawa S; Ito M; Takeshima R; Mizukawa I; Watanabe A; Tada Y
    J Dermatol Sci; 2021 Oct; 104(1):55-62. PubMed ID: 34548208
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fingolimod ameliorates imiquimod-induced psoriasiform dermatitis by sequestrating interleukin-17-producing ?d T cells in secondary lymph nodes.
    Okura I; Kamata M; Asano Y; Mitsui A; Shimizu T; Sato S; Tada Y
    J Dermatol Sci; 2021 May; 102(2):116-125. PubMed ID: 33888401
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-IL-17A and IL-23p19 antibodies but not anti-TNFα antibody induce expansion of regulatory T cells and restoration of their suppressive function in imiquimod-induced psoriasiform dermatitis.
    Shimizu T; Kamata M; Fukaya S; Hayashi K; Fukuyasu A; Tanaka T; Ishikawa T; Ohnishi T; Tada Y
    J Dermatol Sci; 2019 Sep; 95(3):90-98. PubMed ID: 31362906
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The vitamin D
    Hau CS; Shimizu T; Tada Y; Kamata M; Takeoka S; Shibata S; Mitsui A; Asano Y; Sugaya M; Kadono T; Sato S; Watanabe S
    J Dermatol Sci; 2018 Nov; 92(2):117-126. PubMed ID: 30166055
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 5-hydroxytryptophan attenuates imiquimod-induced psoriasiform dermatitis probably through inhibition of IL-17A production and keratinocyte activation.
    Hsu PY; Yang HJ; Yang TH; Su CC
    Exp Dermatol; 2018 Nov; 27(11):1273-1279. PubMed ID: 30221419
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hyperforin Ameliorates Imiquimod-Induced Psoriasis-Like Murine Skin Inflammation by Modulating IL-17A-Producing γδ T Cells.
    Zhang S; Zhang J; Yu J; Chen X; Zhang F; Wei W; Zhang L; Chen W; Lin N; Wu Y
    Front Immunol; 2021; 12():635076. PubMed ID: 34025642
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Calcipotriol and betamethasone dipropionate exhibit different immunomodulatory effects on imiquimod-induced murine psoriasiform dermatitis.
    Takeoka S; Shimizu T; Kamata M; Hau CS; Fukaya S; Hayashi K; Fukuyasu A; Tanaka T; Ishikawa T; Ohnishi T; Tada Y
    J Dermatol; 2020 Feb; 47(2):155-162. PubMed ID: 31762070
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Indirubin ameliorates imiquimod-induced psoriasis-like skin lesions in mice by inhibiting inflammatory responses mediated by IL-17A-producing γδ T cells.
    Xie XJ; Di TT; Wang Y; Wang MX; Meng YJ; Lin Y; Xu XL; Li P; Zhao JX
    Mol Immunol; 2018 Sep; 101():386-395. PubMed ID: 30064075
    [TBL] [Abstract][Full Text] [Related]  

  • 9. C5a/C5aR1 mediates IMQ-induced psoriasiform skin inflammation by promoting IL-17A production from γδ-T cells.
    Zheng QY; Xu F; Yang Y; Sun DD; Zhong Y; Wu S; Li GQ; Gao WW; Wang T; Xu GL; Liang SJ
    FASEB J; 2020 Aug; 34(8):10590-10604. PubMed ID: 32557852
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of γ-secretase inhibitor on Th17 cell differentiation and function of mouse psoriasis-like skin inflammation.
    Ma L; Xue H; Qi R; Wang Y; Yuan L
    J Transl Med; 2018 Mar; 16(1):59. PubMed ID: 29523162
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of IL-17-committed T cells in a murine psoriasis model by a vitamin D analogue.
    Kusuba N; Kitoh A; Dainichi T; Honda T; Otsuka A; Egawa G; Nakajima S; Miyachi Y; Kabashima K
    J Allergy Clin Immunol; 2018 Mar; 141(3):972-981.e10. PubMed ID: 28870465
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Skin-penetrating methotrexate alleviates imiquimod-induced psoriasiform dermatitis via decreasing IL-17-producing gamma delta T cells.
    Byamba D; Kim DY; Kim DS; Kim TG; Jee H; Kim SH; Park TY; Yang SH; Lee SK; Lee MG
    Exp Dermatol; 2014 Jul; 23(7):492-6. PubMed ID: 24824846
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Resolvin D1 attenuates imiquimod-induced mice psoriasiform dermatitis through MAPKs and NF-κB pathways.
    Xu J; Duan X; Hu F; Poorun D; Liu X; Wang X; Zhang S; Gan L; He M; Zhu K; Ming Z; Chen H
    J Dermatol Sci; 2018 Feb; 89(2):127-135. PubMed ID: 29137840
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Liangxue Jiedu formula improves imiquimod-induced psoriasiform dermatitis with circadian desynchrony by regulating Th17 cell differentiation based on network pharmacological analysis.
    Xie X; Zhang L; Lin Y; Liu X; Han X; Li P
    J Ethnopharmacol; 2023 Dec; 317():116807. PubMed ID: 37331449
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of interleukin-2-inducible T-cell kinase causes reduction in imiquimod-induced psoriasiform inflammation through reduction of Th17 cells and enhancement of Treg cells in mice.
    Nadeem A; Ahmad SF; Al-Harbi NO; Ibrahim KE; Alqahtani F; As Sobeai HM; Alotaibi MR
    Biochimie; 2020 Dec; 179():146-156. PubMed ID: 33007409
    [TBL] [Abstract][Full Text] [Related]  

  • 16. IL-23 from Langerhans cells is required for the development of imiquimod-induced psoriasis-like dermatitis by induction of IL-17A-producing γδ T cells.
    Yoshiki R; Kabashima K; Honda T; Nakamizo S; Sawada Y; Sugita K; Yoshioka H; Ohmori S; Malissen B; Tokura Y; Nakamura M
    J Invest Dermatol; 2014 Jul; 134(7):1912-1921. PubMed ID: 24569709
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Apremilast increases IL-10-producing regulatory B cells and decreases proinflammatory T cells and innate cells in psoriatic arthritis and psoriasis.
    Mavropoulos A; Zafiriou E; Simopoulou T; Brotis AG; Liaskos C; Roussaki-Schulze A; Katsiari CG; Bogdanos DP; Sakkas LI
    Rheumatology (Oxford); 2019 Dec; 58(12):2240-2250. PubMed ID: 31209492
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Losartan ointment attenuates imiquimod-induced psoriasis-like inflammation.
    Shokrian Zeini M; Haddadi NS; Shayan M; Shokrian Zeini M; Kazemi K; Solaimanian S; Abdollahifar MA; Hedayatyanfard K; Dehpour AR
    Int Immunopharmacol; 2021 Nov; 100():108160. PubMed ID: 34583123
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bruton's tyrosine kinase inhibitor suppresses imiquimod-induced psoriasis-like inflammation in mice through regulation of IL-23/IL-17A in innate immune cells.
    Nadeem A; Ahmad SF; Al-Harbi NO; El-Sherbeeny AM; Alasmari AF; Alanazi WA; Alasmari F; Ibrahim KE; Al-Harbi MM; Bakheet SA; Attia SM
    Int Immunopharmacol; 2020 Mar; 80():106215. PubMed ID: 31982823
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Capsaicin attenuates imiquimod-induced epidermal hyperplasia and cutaneous inflammation in a murine model of psoriasis.
    Chan TC; Lee MS; Huang WC; Chang WY; Krueger JG; Tsai TF
    Biomed Pharmacother; 2021 Sep; 141():111950. PubMed ID: 34328106
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.